Logo image of CLM.CA

CONSOLIDATED LITHIUM METALS (CLM.CA) Stock Fundamental Analysis

TSX-V:CLM - TSX Venture Exchange - CA2094161064 - Common Stock - Currency: CAD

0.005  0 (-50%)

Fundamental Rating

1

Taking everything into account, CLM scores 1 out of 10 in our fundamental rating. CLM was compared to 822 industry peers in the Metals & Mining industry. CLM has a bad profitability rating. Also its financial health evaluation is rather negative. CLM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLM has reported negative net income.
CLM had a negative operating cash flow in the past year.
CLM.CA Yearly Net Income VS EBIT VS OCF VS FCFCLM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

CLM has a worse Return On Assets (-809.24%) than 86.91% of its industry peers.
Looking at the Return On Equity, with a value of -3535.40%, CLM is doing worse than 76.61% of the companies in the same industry.
Industry RankSector Rank
ROA -809.24%
ROE -3535.4%
ROIC N/A
ROA(3y)-156.13%
ROA(5y)N/A
ROE(3y)-283.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLM.CA Yearly ROA, ROE, ROICCLM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100 -200 -300

1.3 Margins

CLM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLM.CA Yearly Profit, Operating, Gross MarginsCLM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CLM has been increased compared to 1 year ago.
CLM has a better debt/assets ratio than last year.
CLM.CA Yearly Shares OutstandingCLM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M
CLM.CA Yearly Total Debt VS Total AssetsCLM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -119.14, we must say that CLM is in the distress zone and has some risk of bankruptcy.
CLM's Altman-Z score of -119.14 is on the low side compared to the rest of the industry. CLM is outperformed by 83.03% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that CLM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.44, CLM is not doing good in the industry: 70.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z -119.14
ROIC/WACCN/A
WACCN/A
CLM.CA Yearly LT Debt VS Equity VS FCFCLM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M -4M

2.3 Liquidity

CLM has a Current Ratio of 1.11. This is a normal value and indicates that CLM is financially healthy and should not expect problems in meeting its short term obligations.
CLM's Current ratio of 1.11 is in line compared to the rest of the industry. CLM outperforms 44.73% of its industry peers.
A Quick Ratio of 1.11 indicates that CLM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.11, CLM perfoms like the industry average, outperforming 47.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
CLM.CA Yearly Current Assets VS Current LiabilitesCLM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

CLM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.97%, which is quite impressive.
EPS 1Y (TTM)53.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLM.CA Yearly Revenue VS EstimatesCLM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
CLM.CA Yearly EPS VS EstimatesCLM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CLM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLM.CA Price Earnings VS Forward Price EarningsCLM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLM.CA Per share dataCLM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONSOLIDATED LITHIUM METALS

TSX-V:CLM (3/7/2025, 7:00:00 PM)

0.005

0 (-50%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.87%
Ins Owner ChangeN/A
Market Cap1.84M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 17.02
P/tB 17.02
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -809.24%
ROE -3535.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-156.13%
ROA(5y)N/A
ROE(3y)-283.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z -119.14
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.48%
OCF growth 3YN/A
OCF growth 5YN/A